Endoscopy equipment market to hit USD 53.54 billion

The global endoscopy equipment market, valued at USD 34.83 billion in 2024, stood at USD 37.08 billion in 2025 and is projected to advance at a resilient CAGR of 7.6% from 2025 to 2030, culminating in a forecasted valuation of USD 53.54 billion by the end of the period. The growth of the endoscopy equipment market is driven by the rising need for endoscopy in diagnosing and treating critical diseases, increasing investments and grants from governments and organizations, and the growing prevalence of inflammatory bowel disease and colorectal cancer. Additionally, hospitals are expanding their endoscopic capabilities, fueled by the increasing demand for minimally invasive procedures and ongoing technological advancements. The rising adoption of single-use endoscopy instruments and the growing trend toward automated endoscope reprocessing, which enhances efficiency, reduces infection risks, and meets stringent hygiene standards, drives the endoscopy equipment market.

By product, the endoscopy equipment market is segmented into endoscopes, visualization systems, other endoscopy equipment, and accessories. The endoscopes segment is further divided into the rigid endoscopes, flexible endoscopes, robot-assisted endoscopes, and capsule endoscopes. In 2024, rigid endoscopes held a significant market share and are expected to lead during the forecast period. Laparoscopy holds the largest market due to its adoption in minimally invasive surgeries, whereas bronchoscopy is expected to record the fastest growth, driven by the increasing burden of respiratory diseases, particularly lung cancer. Laparoscopy offers significant clinical advantages such as reduced surgical-site infection (SSI) risks, smaller incisions, faster recovery times, and shorter hospital stays compared to open surgeries, making it the preferred choice for patients and physicians.

The growing prevalence of gastrointestinal disorders and urinary system complications has further driven the demand for laparoscopic interventions. Additionally, laparoscopic cholecystectomy, a safe and cost-effective alternative to open gallbladder removal, has gained widespread acceptance, reinforcing the dominance of this segment. Increasing patient preference for minimally invasive procedures, combined with the long-term cost savings and improved clinical outcomes associated with laparoscopic surgeries, has positioned laparoscopes as an indispensable equipment in modern healthcare.

By application, the endoscopy equipment market is segmented by application into gastrointestinal endoscopy, bronchoscopy, ENT endoscopy, urology endoscopy (cystoscopy), laparoscopy, obstetrics/gynecology endoscopy, arthroscopy, mediastinoscopy, and other applications.

Among these, the bronchoscopy application is expected to grow at the fastest rate during the forecast period due to the rising global burden of respiratory diseases, particularly lung cancer. According to the American Cancer Society, in 2025, the US alone is expected to witness approximately 226,650 new lung cancer cases and 124,730 related deaths, highlighting the critical need for early detection and continuous monitoring. Bronchoscopes are widely used for diagnostic and therapeutic purposes, including tissue biopsy, airway examination, and interventional procedures such as stent placements or foreign body removal. The growing adoption of minimally invasive techniques, along with video and disposable bronchoscopes, further accelerates segment growth. Additionally, the rising prevalence of chronic respiratory diseases such as COPD, asthma, and infections, along with increasing demand for same-day outpatient bronchoscopy procedures, positions this segment as a key revenue driver in the endoscopy equipment market.

By geography, the endoscopy equipment market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America commanded the largest share in 2024, driven by a strong prevalence of chronic diseases, high procedural volumes, and substantial healthcare investments. For instance, according to the American Cancer Society, the US alone reported approximately 2,001,140 new cancer cases and 611,720 cancer-related deaths in 2024, underscoring a significant demand for early diagnostic and therapeutic procedures such as endoscopy.

Furthermore, gastrointestinal disorders remain highly prevalent, with a National Library of Medicine article (May 2025) highlighting that 23.5 million GI endoscopies were performed in 2022. Robust research funding also supports market expansion, with the National Institutes of Health allocating USD 3.6 billion to GI research in 2023, accounting for 7.4% of its total budget. Advanced healthcare infrastructure, favorable reimbursement policies, and rapid adoption of minimally invasive technologies further strengthen the region’s dominance. Additionally, the presence of leading global manufacturers, coupled with continuous technological innovations such as AI-integrated and disposable endoscopes, enhances accessibility and efficiency, reinforcing North America’s position as the largest revenue-generating region in the global endoscopy equipment market. MarketsandMarkets